Aimmune Therapeutics Inc Stock Price (AIMT)

Key Statistics

Open
Previous Close
Bid
Ask
Day Range -
52 Week Range -
Volume
Avg. Volume
Volume to USD
Market Cap
Beta
PE Ratio
Latest EPS
EPS TTM
Dividend
Dividend Yield
Ex-Dividend Date
Revenue TTM
Revenue per Share
Revenue per Employee
Profit Margin
Gross Profit TTM
Total Cash TTM
Total Debt TTM

Share Distribution

Shares Outstanding
Float
Short Interest
Short Ratio
Insider Ownership
Institution Ownership

Latest Headlines

Omega Healthcare Investors, Inc. (NYSE:OHI) Stake Raised by Wedbush Securities Inc.Mon, 4 Jul 2022 04:38:59 UTC via ETF Daily News
Horizon Therapeutics Public Limited (NASDAQ:HZNP) Shares Bought by Wedbush Securities Inc.Mon, 4 Jul 2022 04:38:57 UTC via ETF Daily News
iShares U.S. Healthcare Providers ETF (NYSEARCA:IHF) Shares Sold by AE Wealth Management LLCMon, 4 Jul 2022 04:34:52 UTC via ETF Daily News
National HealthCare Co. (NYSEAMERICAN:NHC) Shares Sold by AE Wealth Management LLCMon, 4 Jul 2022 04:22:47 UTC via ETF Daily News
Spire Wealth Management Has $267,000 Stock Holdings in Healthcare Services Group, Inc. (NASDAQ:HCSG)Mon, 4 Jul 2022 04:20:53 UTC via ETF Daily News
Calliditas Therapeutics AB (publ) (NASDAQ:CALT) Short Interest UpdateMon, 4 Jul 2022 03:12:47 UTC via ETF Daily News
Acer Therapeutics Inc. (NASDAQ:ACER) Short Interest Down 24.6% in JuneMon, 4 Jul 2022 02:52:49 UTC via ETF Daily News
Short Interest in Addex Therapeutics Ltd (NASDAQ:ADXN) Increases By 29.2%Mon, 4 Jul 2022 02:52:41 UTC via ETF Daily News
Candel Therapeutics (NASDAQ:CADL) versus Fusion Pharmaceuticals (NASDAQ:FUSN) Head-To-Head ReviewMon, 4 Jul 2022 02:19:08 UTC via ETF Daily News
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Given Consensus Recommendation of “Hold” by BrokeragesMon, 4 Jul 2022 02:19:03 UTC via ETF Daily News

Aimmune Therapeutics Inc Performance

5 Day Change 1 Month Change 30 Day Change 3 Month Change 90 Day Change 6 Month Change 180 Day Change Year to Date Change 1 Year Change 2 Year Change 5 Year Change

Active Alerts for IEX:AIMT

You don't have any alerts set for IEX:AIMT.

About Aimmune Therapeutics Inc

Aimmune Therapeutics Inc is engaged in the field of biotechnology. It researches and develops drug candidates for the treatment of peanut and other food allergies.

CEOJayson Donald Alexander Dallas IndustryBiotechnology SectorHealthcare Websitehttps://www.aimmune.com Issue ExchangeNasdaq Global Select Issue TypeUnknown

Real-time AIMT to USD Trade Analysis on IEX

Market Status Closed

Analysis is available when the exchange & market are open.